Coffee Shown to Decrease Fibrosis
More and more research is emerging suggesting that coffee may be beneficial to your health. Most recently, a study published in the February 2012 issue of Hepatology is the first to show the connection between coffee consumption and a decreased amount of connective tissue (fibrosis) in people with nonalcoholic fatty liver disease ("NAFLD").
The researchers, who are based at Brooke Army Medical Center in Fort Sam Houston, Texas, interviewed 306 adults who had been diagnosed with NAFLD about their coffee intake. They also conducted ultrasounds in order to place the participants in four categories: no fibrosis, steatosis, NASH stage 0-1 and NASH stage 2-4. NASH is the most extreme form of NAFLD.
They discovered that the participants in the NASH stage 0-1 group got 58% of their caffeine from regular coffee, whereas the NASH stage 2-4 group (the more advanced disease group) got only 36% of their caffeine from regular coffee.
The conclusion? Coffee consumption decreases the build-up of connective tissues in the liver of people with NASH. The researchers stated that more studies need to be conducted to determine the ideal amount of coffee that should be consumed as well as the exact connection between caffeine and liver disease.
Coffee has been linked with a wide range of health benefits, including a reduced risk of developing diabetes, prostate cancer, cirrhosis, liver disease and oral cavities. Additionally, many studies have also shown that people who drink coffee regularly are up to 80% less likely to develop Parkinson’s disease. These benefits are generally attributed to the powerful antioxidants found in coffee called polyphenols.